Provided by the American Epilepsy Society
Release Date: August 30, 2021
Expiration Date: August 30, 2024

Overview
Self-Assessment in Epilepsy (SAE) Volume is designed to assist members in fulfilling their Maintenance of Certification (MOC ) requirement to participate in a self-assessment activity. SAE Volume 5.1 can also be used as a study tool for the subspecialty certifying examination.

This activity consists of 100 questions that test the learner’s knowledge and competence. Feedback on each question is provided immediately following the question, along with references, and peer benchmarking data is provided once the learner completes all 100 questions. The learner does not have to complete all questions at once but can “bookmark” their place in the activity.

The purpose of self-assessment is to provide a basis for selecting focused continuing medical education, lifelong learning, and/or career development. Please see the Learning Objectives below for information on the specific topics covered in this activity.

Following participation in this activity, learners should be able to:

1.) Self-assess their knowledge and competence regarding:
• basic mechanisms of the epilepsies,
• clinical presentation of the disorder,
• differential diagnosis,
• classification of seizures and epilepsies,
• diverse etiologies of the epilepsies,
• appropriate diagnostic evaluation and test selection,
• principles of management,
• system-based practice issues,
• specific needs of subpopulations with epilepsy
• Benchmark their individual results against aggregate peer results on the questions.

2.) Self-reflect and utilize their results as the basis for the selection of additional educational activities and/or resources for further study.

Neurologists, including Adult and Pediatric Epileptologists, who anticipate obtaining certification by The American Board of Psychiatry and Neurology (ABPN) in Epilepsy or other interested physicians.

The American Epilepsy Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Epilepsy Society designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

International Credits: The American Medical Association has determined that non-US. licensed physicians who participate in this CME activity are eligible for AMA PRA Category 1 Credits™.

Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 8.0 hours of Category 1 credit for completing this program.

Maintenance of Certification: The American Board of Psychiatry and Neurology has reviewed the Self-Assessment in Epilepsy (SAE) Volume 6 activity and has approved this program as part of a comprehensive self-assessment program, which is mandated by the ABMS as a necessary component of maintenance of certification.

If you have any questions regarding MOC, please contact the American Board of Psychiatry and Neurology at: questions@abpn.com or their MOC Helpline at 847.229.6512 for more information.

In accordance with the ACCME Standards for Commercial Support, the AES requires that any person who is in a position to control content of a CME activity must disclose all relevant financial relationships that they have with a commercial interest. Unless otherwise indicated, none of the planners or faculty of this activity have any relevant relationships to disclose. All relevant financial relationships have been mitigated. The following individuals contributed to this activity’s content.The following individuals contributed to this activity’s content.

Planning Committee Members
Jeremy Moeller, M.D., Yale University School of Medicine, New Haven, CT
Sudha Kessler, M.D., Children’s Hospital of Philadelphia, Philadelphia, PA

Faculty/Question Writers
Jayant N. Acharya, MD-Lundbeck LLC: Consulting Fees (e.g., advisory boards); Other Financial or Material Support: travel expenses to advisory board meeting; Sunovion-Honoraria; Other Financial or Material Support, travel expenses to speaker training meeting;
UCB Pharma-Speaker’s Bureau Member, Honoraria
Vinita Acharya, MD
Dara Albert, D.O
Rohit R. Das, MD, MPH-LivaNova: Honoraria; Neurotech: Consulting fees
Lawrence Eisenman, MD, PhD
Nina Garga, MD
Elizabeth Gerard, MD-SAGE Therapeutics: Contracted Research; UCB China: Honoraria
Leena Kansal, MD
Sudha Kessler, MD
Kelly Knupp, MD-PERF:Grant, Other Financial or Material Support; Zogenix: Grant, Principal Investigator/Co-Investigator, Other Financial or Material Support
Jack Lin, MD-Sunovion: Honoraria; UCP Pharma-Honoraria
Paul H. McCabe, MD-Eisai-Speakers Bureau Member, Honoraria; Sunovion- Speakers Bureau Member, Honoraria; UCB-Speakers Bureau Member, Honoraria
Amy McGregor, MD-Oxford University Press: Honoraria
Jeremy Moeller, MD
Jun T. Park, MD
Sarah E. Schmitt, MD-Sage Therapeutics: Salary

CME Reviewers
The following reviewers have indicated they have no financial relationships to disclose relevant to this activity:
Derek Bauer, M.D., University of Virginia, Charlottesville, VA
Fawad A. Khan, M.D., Ochsner Neuroscience Institute, New Orleans, LA

AES Staff
The following staff members have indicated they have no financial relationships to disclose relevant to this activity:
Kandice Kidd, MA, eLearning Manager

Resolution of Conflicts of Interest
It is the policy of the American Epilepsy Society to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. In accordance with the ACCME Standards for Commercial Support of CME, the AES implemented the mechanisms of prospective peer review of this CME activity, to identify and resolve any conflicts. Additionally, the content of this activity is based on the best available evidence.

Unapproved Use Disclosure
The American Epilepsy Society requires CME authors to disclose to learners when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information. Information about pharmaceutical agents/devices that is outside of U.S. Food and Drug Administration approved labeling may be contained in this activity.

Disclaimer
This CME activity is for educational purposes only and does not constitute the opinion or endorsement of, or promotion by, the American Epilepsy Society. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label, investigational and/or experimental uses.

CME Information
In order to receive your CME certificate, you must successfully complete all 100 questions in the activity and submit the completed evaluation.

Contact Information
For further information or assistance with this activity contact the American Epilepsy Society at education@aesnet.org or call 312.883.3800.